報價延遲最少15分鐘:2025/08/25 16:58 EDT
盤後時段
|
||||
|
42.66 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
42.66
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-8.22/0.86
|
|
企業價值
385.75M
|
| 資產負債 |
|
每股賬面淨值
-1.72
|
| 現金流量 |
|
現金流量率
0.00
|
| 損益表 |
|
收益
32.63M
|
|
每股收益
0.09
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/08/25 16:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing. |
